Donor specific anti-hla antibodies (DSA) in haploidentical stem cell transplantation with post transplant cyclophosphamide: Risk of graft failure, poor graft function and impact on outcomes

被引：0
|
作者：
Bramanti, Stefania [1 ]
Calafiore, Valeria [1 ]
Longhi, Elena [2 ]
Mariotti, Jacopo [1 ]
Crespiatico, Loretta [2 ]
Sarina, Barbara [1 ]
Nocco, Angela [2 ]
De Philippis, Chiara [1 ]
Santoro, Armando [1 ]
Castagna, Luca [1 ]
机构：
[1] Ist Clin Humanitas, Rozzano, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P660
引用
收藏
页码：562 / 563
页数：2
相关论文
共 50 条
  • [41] Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation
    张荣莉
    China Medical Abstracts (Internal Medicine), 2018, 35 (02) : 117 - 117
  • [42] MONITORING OF DONOR SPECIFIC ANTI-HLA ANTIBODIES (DSA) IN KIDNEY TRANSPLANTATION PATIENTS
    Bardi, Rafika
    Ben Boujemaa, S.
    Kallala, Ch
    Ayed, S.
    Makhlouf, M.
    Ben Romdhane, T.
    Becha, M.
    Abderrahim, E.
    Ben Abdallah, T.
    Gorgi, Y.
    TISSUE ANTIGENS, 2012, 79 (06): : 497 - 497
  • [43] Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders
    Albert, Michael H.
    Sirin, Mehtap
    Hoenig, Manfred
    Hauck, Fabian
    Schuetz, Catharina
    Bhattacharyya, Rajat
    Stepensky, Polina
    Jacoby, Elad
    Gungor, Tayfun
    Beier, Rita
    Schulz, Ansgar
    BONE MARROW TRANSPLANTATION, 2021, 56 (09) : 2248 - 2258
  • [44] Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders
    Michael H. Albert
    Mehtap Sirin
    Manfred Hoenig
    Fabian Hauck
    Catharina Schuetz
    Rajat Bhattacharyya
    Polina Stepensky
    Elad Jacoby
    Tayfun Güngör
    Rita Beier
    Ansgar Schulz
    Bone Marrow Transplantation, 2021, 56 : 2248 - 2258
  • [45] Pre transplant donor specific antibodies are associated with poor graft function after islet cell transplantation
    Ryan, E
    Halpin, A
    Imes, S
    Shapiro, J
    HUMAN IMMUNOLOGY, 2005, 66 : S6 - S6
  • [46] IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients
    Hamdani, Gilad
    Goebel, Jens W.
    Brailey, Paul
    Portwood, Elizabeth A.
    Hooper, David K.
    Girnita, Alin L.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (05)
  • [47] De novo donor-specific anti-HLA antibodies are a risk factor for graft loss in DCD liver transplantation
    Andacoglu, Oya
    Ellis, Thomas
    D'Alessandro, Anthony M.
    Foley, David
    Powell, Amy
    Leverson, Glen E.
    Lucey, Michael R.
    Musat, Alexandru I.
    HEPATOLOGY, 2013, 58 : 211A - 211A
  • [48] ANTI-HLA DONOR SPECIFIC COMPLEMENT FIXING ANTIBODIES IN KIDNEY GRAFT PATIENTS
    Suarez, Natalia
    Gonzalez, Azucena
    Mensa, Anna
    Digon, Monserrat
    Anton, Maria C.
    Martorell, Jaume
    Ercilla, Guadalupe
    TRANSPLANT INTERNATIONAL, 2013, 26 : 77 - 77
  • [49] Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
    Morin-Zorman, Sarah
    Loiseau, Pascale
    Taupin, Jean-Luc
    Caillat-Zucman, Sophie
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [50] Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
    Betjes, Michiel G. H.
    Sablik, Kasia S.
    Otten, Henny G.
    Roelen, Dave L.
    Claas, Frans H.
    de Weerd, Annelies
    JOURNAL OF TRANSPLANTATION, 2020, 2020
12345